107 related articles for article (PubMed ID: 6858934)
1. Efficacy, safety, and pharmacokinetics of a concentration-maintaining regimen of intravenous pirmenol.
Reiter MJ; Hammill SC; Shand DG; Verghese C; McCarthy E; Pritchett EL
Am J Cardiol; 1983 Jul; 52(1):83-7. PubMed ID: 6858934
[TBL] [Abstract][Full Text] [Related]
2. Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics.
Hammill SC; Shand DG; Routledge PA; Hindman MC; Baker JT; Pritchett EL
Circulation; 1982 Feb; 65(2):369-75. PubMed ID: 7053896
[TBL] [Abstract][Full Text] [Related]
3. The relation of the kinetics of pirmenol to its antiarrhythmic efficacy.
Johnson BF; Haffajee CI; Woodman T; Sloan KL
J Clin Pharmacol; 1988 May; 28(5):401-5. PubMed ID: 3392237
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and pharmacokinetics of oral pirmenol, a new antiarrhythmic drug.
Garg DC; Jallad NS; Singh S; Ng KF; Weidler DJ
J Clin Pharmacol; 1988 Sep; 28(9):812-7. PubMed ID: 2466056
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of intravenous pirmenol hydrochloride for treatment of ventricular arrhythmias: a controlled comparison with lidocaine.
Anderson JL; Lutz JR; Sanders SW; Nappi JM
J Cardiovasc Pharmacol; 1983; 5(2):213-20. PubMed ID: 6188892
[No Abstract] [Full Text] [Related]
6. Hemodynamic effects of pirmenol, a new antiarrhythmic agent, assessed noninvasively.
Toivonen LK; Nieminen MS
Int J Cardiol; 1986 Feb; 10(2):111-8. PubMed ID: 3943931
[TBL] [Abstract][Full Text] [Related]
7. Acute haemodynamic effects of the antiarrhythmic agent pirmenol in cardiac patients: a comparison with lidocaine.
Nieminen MS; Toivonen LK; Manninen V; Frick MH
Eur Heart J; 1986 Feb; 7(2):150-7. PubMed ID: 3516703
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and efficacy of pirmenol hydrochloride in the treatment of ventricular dysrhythmia.
Lee TG; Goldberg AD; Chang T; Serkland MT; Yakatan GJ; Johnson EL; Toole JG; Goldstein S
J Cardiovasc Pharmacol; 1983; 5(4):632-7. PubMed ID: 6193362
[TBL] [Abstract][Full Text] [Related]
9. Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. A placebo controlled study.
Toivonen LK; Nieminen MS; Manninen V; Frick MH
Br Heart J; 1986 Feb; 55(2):176-80. PubMed ID: 3510642
[TBL] [Abstract][Full Text] [Related]
10. Pirmenol: an antiarrhythmic drug with unique electrocardiographic features--a double-blind placebo-controlled comparison with quinidine.
Salerno DM; Fifield J; Farmer C; Hodges M
Clin Cardiol; 1991 Jan; 14(1):25-32. PubMed ID: 2019027
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic efficacy of pirmenol in the treatment of premature ventricular complexes.
Toivonen LK; Nieminen MS; Manninen V; Frick MH
Eur Heart J; 1985 Sep; 6(9):737-44. PubMed ID: 2416566
[TBL] [Abstract][Full Text] [Related]
12. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics and pharmacokinetics of oral pirmenol.
Ellenbogen KA; Roark SF; Sintetos AL; Smith MS; McCarthy EA; Smith WM; Kates RE; Pritchett EL
Clin Pharmacol Ther; 1987 Oct; 42(4):405-10. PubMed ID: 3665339
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
Kjekshus J; Bathen J; Orning OM; Storstein L
Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of pirmenol and lidocaine: a placebo-controlled, double-blind, comparative study.
Nieminen MS; Toivonen L; Manninen V; Frick H
Am J Cardiol; 1987 Jun; 59(16):27H-32H. PubMed ID: 3296728
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of oral pirmenol in suppressing ventricular premature depolarizations.
de Buitleir M; Crevey BJ; Johnson T; Kou WH; Nelson SD; Schmaltz S; Morady F
Am Heart J; 1988 Aug; 116(2 Pt 1):379-84. PubMed ID: 2456681
[TBL] [Abstract][Full Text] [Related]
17. Preliminary study of pirmenol in the treatment of ventricular arrhythmias.
Gimeno Gascon JV; Algarra Vidal FJ
Am J Cardiol; 1987 Jun; 59(16):53H. PubMed ID: 3591713
[TBL] [Abstract][Full Text] [Related]
18. Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias.
Hampton EM; Anderson JL; Lutz JR; Nappi JM
Eur J Clin Pharmacol; 1986; 31(1):15-22. PubMed ID: 3780822
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyarrhythmias.
Liem LB; Clay DA; Franz MR; Swerdlow CD
Am Heart J; 1987 Jun; 113(6):1390-6. PubMed ID: 3591608
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic evaluation of pirmenol for sustained ventricular tachycardia secondary to coronary artery disease.
Easley AR; Mann DE; Reiter MJ; Sakun V; Sullivan SM; Magro SA; Luck JC; Wyndham CR
Am J Cardiol; 1986 Jul; 58(1):86-9. PubMed ID: 3728337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
